• Evolution of Virus inactivation methods in manufacture of biologics

  • Auteur(s): DD ENTERPRISES
  • Podcast

Evolution of Virus inactivation methods in manufacture of biologics

Auteur(s): DD ENTERPRISES
Écouter gratuitement

  • Résumé

  • Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses. DNA-based herpesviruses and RNA-based retroviruses are examples of enveloped viruses; DNA-based adenoviruses and RNA-based parvoviruses are examples of nonenveloped viruses.


    Visit Site>> Click Here
    Copyright 2024 DD ENTERPRISES
    Voir plus Voir moins
Sciences sociales
Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2
Épisodes
  • Evolution of Virus inactivation methods in manufacture of biologics

    Evolution of Virus inactivation methods in manufacture of biologics
    May 29 2024

    Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses.


    Visit Site>> Click Here
    Voir plus Voir moins
    19 min

Ce que les auditeurs disent de Evolution of Virus inactivation methods in manufacture of biologics

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.